NCT00321126

Brief Summary

Shigellosis is a major cause of morbidity and mortality in young children in Bangladesh and other developing countries. Further, the increasing emergence of resistance to a wide range of antibiotics is of great concern. Another major public health problem in Bangladesh is malnutrition, which is closely linked with shigellosis and with a high mortality. In Shigellosis, a heavy nutritional burden is placed on children and vital micronutrients such as vitamin A is lost in the urine. We recently found that the immune response in S. Flexneri infection was lower in children who were severely malnourished (weight-for-age≤65% as a percentage of the National Centre for Health Statistics median) when compared to children with weight-for-age from \>65-75%. T cell responses were primarily affected with lowered CD4/CD8 ratios, lowered proliferative responses to T cell mitogens, Conconavalin A (ConA) and phytohaemagglutinin (PHA). However, proliferation of pheripheral blood mononuclear cells (PBMs) was lowered only in the presence of autologous plasma suggesting that a factor(s) in plasma, probably nutritional, rather than a defect in cells themselves was responsible. In children with S. dysenteriae 1 infection, proliferative responses to PHA were similarly lowered in the presence of autologous plasma but inhibition correlated to lowered transferring levels in plasma and not to the weight-for-age of the children. Also severely malnourished children with either S. flexneri or S. dysenteriae 1 infection were more severely ill. These findingings show that immunity in malnourishrd children with shigella infection is impaired which may lead to more severe illness. As zinc has profound effects on immunity as well as clinical outcome in diarrhoeal diseases, it is possible that zinc deficiency may be a factor in reducing immunity and increasing severity of acute illness in malnourished children with shigellosis. In this study, we will investigate the effect of zinc supplementation, in a double blind placebo controlled trial, on inflammatory responses, outcome of acute illness and growth following recovery from acute illness with S. flexneri infection.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jan 1999

Typical duration for phase_3

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1999

Completed
3.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2002

Completed
4.1 years until next milestone

First Submitted

Initial submission to the registry

May 2, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 3, 2006

Completed
Last Updated

May 3, 2006

Status Verified

May 1, 2006

First QC Date

May 2, 2006

Last Update Submit

May 2, 2006

Conditions

Keywords

ZincShigellaChildrenBangladesh

Outcome Measures

Primary Outcomes (7)

  • Age

  • Sex

  • Weight

  • Body Mass index

  • Duration of diarrhoea before admission

  • Stool volume

  • Dehydration status

Secondary Outcomes (8)

  • In blood: total and differential WBC counts,C-reactive protein, albumin, serum electrolytes and creatinine concentration

  • Quantitation of luminal neutriphils

  • Immune response

  • Duration of recovery

  • Presence of blood and mucous in stool

  • +3 more secondary outcomes

Interventions

Eligibility Criteria

Age12 Months - 59 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age between 12-59 months
  • Moderate malnutrition (61-75% Weight / Age - NCHS Median)
  • Duration of diarrhoea of 5 days
  • Culture confirmed shigella spp in stool on enrolment

You may not qualify if:

  • Measles infection in the past six months
  • Presence of obvious systemic illnesses
  • Severe malnutrition
  • Residence in a location requiring a journey of\>2 hour from the Dhaka Hospital of the ICDDR,B
  • Refusal to give consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Roy SK, Raqib R, Khatun W, Azim T, Chowdhury R, Fuchs GJ, Sack DA. Zinc supplementation in the management of shigellosis in malnourished children in Bangladesh. Eur J Clin Nutr. 2008 Jul;62(7):849-55. doi: 10.1038/sj.ejcn.1602795. Epub 2007 Jun 6.

MeSH Terms

Conditions

Dysentery, Bacillary

Condition Hierarchy (Ancestors)

Enterobacteriaceae InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsDysenteryGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Study Officials

  • Swapan Kumar Roy, MBBS, M.Sc, Ph. D

    International Centre for Diarrhoeal Disease Research, Bangladesh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 2, 2006

First Posted

May 3, 2006

Study Start

January 1, 1999

Study Completion

April 1, 2002

Last Updated

May 3, 2006

Record last verified: 2006-05